Beta-blocker therapy was associated with a lower annualized hazard of receiving a clinical diagnosis of Huntington's disease and a slower rate of symptom worsening, observational data showed. (George, ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F.